Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs

Bone Marrow Transplantation

Volumn 28, Issue 4, 2001, Pages 315-321

  Rowley, S D ^a  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ABO compatibility; Bone marrow transplantation; Hemolytic reactions; HSC transplantation; Isoagglutinin

Indexed keywords

AGGLUTININ; ALLOANTIGEN; ANTIMETABOLITE; ERYTHROCYTE ANTIGEN; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TRIMETREXATE;

APHERESIS; BLOOD COMPONENT THERAPY; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; CONTROLLED STUDY; DONOR; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROPOIESIS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RECIPIENT; REVIEW; RISK;

BLOOD GROUP INCOMPATIBILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 0034824007     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703135     Document Type: Review

References (42)

1. ABO blood group system and bone marrow transplantation
2. ABO-incompatible marrow transplants
3. Chromosome mapping of the blood group genes
4. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT
5. a after allogeneic PBPC transplantation
6. ABH incompatible bone marrow transplantation: Removal of erythrocytes by starch sedimentation
7. Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion
8. Hemolytic complications of hematopoietic cell transplantation
9. A to O bone marrow transplantation in severe aplastic anaemia: Dynamics of blood group conversion and demonstration of early dyserythropoiesis in the engrafted marrow
10. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation
11. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: A major ABO mismatch means problems
12. Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia
13. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow
14. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation
15. Hemolysis of transfusion group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate
16. Exchange transfusion the hard way: Massive hemolysis following transplantation of bone marrow with minor ABO incompatibility
17. Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation
18. Rapid engraftment after allogeneic ABO-incompatible peripheral blood stem cell transplantation complicated by severe hemolysis
19. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility
20. Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation
21. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation
22. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components
23. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation
24. ABO-incompatible bone marrow transplantation: The transfusion of incompatible plasma may exacerbate regimen-related toxicity
25. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation
26. A fully automated method for mononuclear bone marrow cell concentration
27. Comparison of progenitor cell concentration techniques: Continuous flow separation versus density-gradient isolation
28. Bone marrow processing with the Fresenius AS 104: Initial results
29. ABH incompatible bone marrow transplantation: Removal of erythrocytes by starch sedimentation
30. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: The effect of leukemic burden, donor HLA-matching, and marrow cell dose
31. Severe delayed hemolytic transfusion reaction complicating an ABO-incompatible bone marrow transplantation
32. Expression of blood group A antigens in human bone marrow cells
33. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant
34. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation
35. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: Evidence for a graft-versus-plasma cell effect
36. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin
37. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin
38. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant
39. +-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation
40. Hemolysis after T-cell depleted bone marrow transplantation involving minor ABO incompatibility
41. Suppression of B cell function by methotrexate and trimetrexate - Evidence for inhibition of purine biosynthesis as a major mechanism of action